Open Access

Blood advances

, том 6 , издание 7 , страницы 2427-2433

COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP

A. Busca ¹

J. Salmanton-García ^{2, 3}

P Corradini ⁴

F. Marchesi ⁵

Alba Cabirta ^{6, 7}

R. DI BLASI ⁸

R. Dulery ⁹

S Lamure ¹⁰

Francesca Farina ¹¹

Barbora Weinbergerova ¹²

Josip Batinić ^{13, 14, 15}

Anna Nordlander ¹⁶

Alberto Lopez-Garcia ¹⁷

Lubos Drgona ¹⁸

Ildefonso Espigado ¹⁹

Iker Falces-Romero ²⁰

Ramón García-Sanz ²¹

Carolina Garcia-Vidal ²²

Anna Guidetti ²³

N Khanna ²⁴

A. Kulasekararaj ²⁵

Johan A. Maertens ²⁶

M. Hoenigl ^{27, 28, 29}

N. Klimko ³⁰

Philipp Koehler ^{2, 3}

Antonio Pagliuca ³¹

Francesco Passamonti ³²

Oliver A. Cornely ^{2, 3, 33, 34}

Livio Pagano ^{35, 36}

Скрыть аффилиации авторов Показать аффилиации авторов: 36 аффилиаций

Stem Cell Transplant Center, Azienda Ospedaliera Universitaria Città della Salute e della Scienza, Turin, Italy; |

Department I of Internal Medicine, Excellence Center for Medical Mycology (ECMM), Faculty of Medicine and University Hospital Cologne, Cologne, Germany; |

Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases, University Hospital Cologne, Cologne, Germany; |

⁴

University of Milan and Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy; |

⁵

Hematology and Stem Cell Transplant Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy;

Научные институты госпитализации и лечения

Национальный институт рака имени Регины Елены

⁶

Department of Hematology, Vall d’Hebron Hospital Universitari, Vall d’Hebron Istitute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain;

Институт онкологии Валь д'Эброн

Университетская больница Валь д'Эброн

⁷

Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain; |

⁸

Hôpital Saint Louis, Assistance Publique–Hôpitaux de Paris (AP-HP), Paris, France; |

⁹

Service d'Hématologie Clinique et de Thérapie Cellulaire, Hôpital Saint Antoine, AP-HP, Unité Mixte de Recherche (UMR) 938, Sorbonne Universitè, Paris, France; |

¹⁰

Department of Clinical Hematology, Montpellier University Hospital, IGMM UMR1535 CNRS, University of Montpellier, Montpellier, France; |

¹¹

IRCCS Ospedale San Raffaele, Milan, Italy; |

¹²

Department of Internal Medicine-Hematology and Oncology, Masaryk University Hospital Brno, Brno, Czech Republic;

Масариков университет

Университетская больница Брно

¹³

University Hospital Centre Zagreb, Zagreb, Croatia; |

¹⁴

Croatian Cooperative Group for Hematological Diseases (CROHEM), Zagreb, Croatia; |

¹⁵

Faculty of Medicine, University of Zagreb, Zagreb, Croatia; |

¹⁶

Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden; |

¹⁷

Fundacion Jimenez-Díaz, Madrid, Spain; |

¹⁸

Comenius University and National Cancer Institute, Bratislava, Slovakia;

Университет имени Яна Амоса Коменского в Братиславе

Национальный институт рака (Словакия)

¹⁹

Hospital Univesitario Virgen del Rocío, Seville, Spain; |

²⁰

La Paz University Hospital, Madrid, Spain; |

²¹

Hospital Universitario de Salamanca, Salamanca, Spain; |

²²

Hospital Clinic, Barcelona, Spain; |

²³

Division of Hematology and Bone Marrow Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, University of Milano, Milan, Italy; |

²⁴

Division of Infectious Diseases and Hospital Epidemiology, Department of Clinical Research, University and University Hospital of Basel, Basel, Switzerland; |

²⁵

King’s College Hospital, London, United Kingdom; |

²⁶

Katholieke Universiteit Leuven, Leuven, Belgium; |

²⁷

Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, San Diego, CA; |

²⁸

Clinical and Translational Fungal Working Group, University of California San Diego, La Jolla, CA; |

²⁹

Division of Infectious Diseases, Department of Internal Medicine, Medical University of Graz, Graz, Austria; |

³⁰

Department of Clinical Mycology, Allergy and Immunology, North Western State Medical University, St Petersburg, Russia; |

³¹

Department of Hematological Medicine, Kings College Hospital, National Health Service Foundation Trust, London, United Kingdom; |

³²

Department of Medicine and Surgery, University of Insubria and Azienda Socio Sanitaria Territoriale Sette Laghi, Ospedale di Circolo of Varese, Varese, Italy; |

³³

University of Cologne, Faculty of Medicine and University Hospital Cologne, Clinical Trials Centre Cologne, Cologne, Germany; |

³⁴

German Centre for Infection Research, Partner Site Bonn-Cologne, Cologne, Germany; |

³⁵

Hematology, IRCCS Fondazione Policlinico Universitario Agostino Gemelli, Rome, Italy; and

Научные институты госпитализации и лечения

Университетская клиника Агостино Джемелли

³⁶

Hematology, Università Cattolica del Sacro Cuore, Rome, Italy |

Тип публикации: Journal Article

Дата публикации: 2022-04-11

American Society of Hematology

Blood advances

scimago Q1

wos Q1

БС1

SJR: 2.901

CiteScore: 11.7

Impact factor: 7.1

ISSN: 24739537, 24739529

DOI: 10.1182/bloodadvances.2021005616

Скопировать DOI

PubMed ID: 34749396

Hematology

Краткое описание

Key Points

The EHA-IDWP developed an observational registry collecting data on COVID-19 infection in patients who received CAR T-cell therapy. Prevalence of COVID-19 was 4.8%, and overall mortality was 50%, highlighting the need for prevention of infection in these patients.

Найдено

1 цитирование

Боголюбова Аполлинария

к.б.н.

36 публикаций, 176 цитирований, 2 рецензии

Индекс Хирша: 9

Национальный медицинский исследовательский центр гематологии

Топ-30

Журналы

	1 2 3 4
Transplant Infectious Disease	Transplant Infectious Disease, 4, 6.25% Transplant Infectious Disease 4 публикации, 6.25%
Frontiers in Oncology	Frontiers in Oncology, 3, 4.69% Frontiers in Oncology 3 публикации, 4.69%
Blood advances	Blood advances, 3, 4.69% Blood advances 3 публикации, 4.69%
Journal for ImmunoTherapy of Cancer	Journal for ImmunoTherapy of Cancer, 2, 3.13% Journal for ImmunoTherapy of Cancer 2 публикации, 3.13%
Experimental Hematology and Oncology	Experimental Hematology and Oncology, 2, 3.13% Experimental Hematology and Oncology 2 публикации, 3.13%
Seminars in Hematology	Seminars in Hematology, 2, 3.13% Seminars in Hematology 2 публикации, 3.13%
Frontiers in Immunology	Frontiers in Immunology, 2, 3.13% Frontiers in Immunology 2 публикации, 3.13%
Clinical and Experimental Medicine	Clinical and Experimental Medicine, 1, 1.56% Clinical and Experimental Medicine 1 публикация, 1.56%
Bone Marrow Transplantation	Bone Marrow Transplantation, 1, 1.56% Bone Marrow Transplantation 1 публикация, 1.56%
Current Oncology Reports	Current Oncology Reports, 1, 1.56% Current Oncology Reports 1 публикация, 1.56%
Cancers	Cancers, 1, 1.56% Cancers 1 публикация, 1.56%
Clinical Microbiology and Infection	Clinical Microbiology and Infection, 1, 1.56% Clinical Microbiology and Infection 1 публикация, 1.56%
Transplant Immunology	Transplant Immunology, 1, 1.56% Transplant Immunology 1 публикация, 1.56%
International Journal of Cancer	International Journal of Cancer, 1, 1.56% International Journal of Cancer 1 публикация, 1.56%
American Society of Clinical Oncology Educational Book	American Society of Clinical Oncology Educational Book, 1, 1.56% American Society of Clinical Oncology Educational Book 1 публикация, 1.56%
Blood and Lymphatic Cancer Targets and Therapy	Blood and Lymphatic Cancer Targets and Therapy, 1, 1.56% Blood and Lymphatic Cancer Targets and Therapy 1 публикация, 1.56%
Expert Review of Anti-Infective Therapy	Expert Review of Anti-Infective Therapy, 1, 1.56% Expert Review of Anti-Infective Therapy 1 публикация, 1.56%
Leukemia and Lymphoma	Leukemia and Lymphoma, 1, 1.56% Leukemia and Lymphoma 1 публикация, 1.56%
Expert Review of Hematology	Expert Review of Hematology, 1, 1.56% Expert Review of Hematology 1 публикация, 1.56%
Blood	Blood, 1, 1.56% Blood 1 публикация, 1.56%
Nature Reviews Clinical Oncology	Nature Reviews Clinical Oncology, 1, 1.56% Nature Reviews Clinical Oncology 1 публикация, 1.56%
Hematology/Oncology Clinics of North America	Hematology/Oncology Clinics of North America, 1, 1.56% Hematology/Oncology Clinics of North America 1 публикация, 1.56%
International Journal of Hematology	International Journal of Hematology, 1, 1.56% International Journal of Hematology 1 публикация, 1.56%
Current Oncology	Current Oncology, 1, 1.56% Current Oncology 1 публикация, 1.56%
Journal of Antimicrobial Chemotherapy	Journal of Antimicrobial Chemotherapy, 1, 1.56% Journal of Antimicrobial Chemotherapy 1 публикация, 1.56%
European Journal of Haematology	European Journal of Haematology, 1, 1.56% European Journal of Haematology 1 публикация, 1.56%
Reviews in Medical Virology	Reviews in Medical Virology, 1, 1.56% Reviews in Medical Virology 1 публикация, 1.56%
British Journal of Haematology	British Journal of Haematology, 1, 1.56% British Journal of Haematology 1 публикация, 1.56%
Frontiers in Cellular and Infection Microbiology	Frontiers in Cellular and Infection Microbiology, 1, 1.56% Frontiers in Cellular and Infection Microbiology 1 публикация, 1.56%
International Journal of Infectious Diseases	International Journal of Infectious Diseases, 1, 1.56% International Journal of Infectious Diseases 1 публикация, 1.56%
	1 2 3 4

Издатели

	2 4 6 8 10 12 14
Springer Nature	Springer Nature, 13, 20.31% Springer Nature 13 публикаций, 20.31%
Elsevier	Elsevier, 10, 15.63% Elsevier 10 публикаций, 15.63%
Wiley	Wiley, 10, 15.63% Wiley 10 публикаций, 15.63%
Frontiers Media S.A.	Frontiers Media S.A., 6, 9.38% Frontiers Media S.A. 6 публикаций, 9.38%
Taylor & Francis	Taylor & Francis, 6, 9.38% Taylor & Francis 6 публикаций, 9.38%
American Society of Hematology	American Society of Hematology, 4, 6.25% American Society of Hematology 4 публикации, 6.25%
MDPI	MDPI, 3, 4.69% MDPI 3 публикации, 4.69%
BMJ	BMJ, 2, 3.13% BMJ 2 публикации, 3.13%
Oxford University Press	Oxford University Press, 2, 3.13% Oxford University Press 2 публикации, 3.13%
Ovid Technologies (Wolters Kluwer Health)	Ovid Technologies (Wolters Kluwer Health), 2, 3.13% Ovid Technologies (Wolters Kluwer Health) 2 публикации, 3.13%
American Society of Clinical Oncology (ASCO)	American Society of Clinical Oncology (ASCO), 1, 1.56% American Society of Clinical Oncology (ASCO) 1 публикация, 1.56%
Research Square Platform LLC	Research Square Platform LLC, 1, 1.56% Research Square Platform LLC 1 публикация, 1.56%
National Medical Research Center of Hematology of the Ministry of Health of the Russian Federation	National Medical Research Center of Hematology of the Ministry of Health of the Russian Federation, 1, 1.56% National Medical Research Center of Hematology of the Ministry of Health of the Russian Federation 1 публикация, 1.56%
American Medical Association (AMA)	American Medical Association (AMA), 1, 1.56% American Medical Association (AMA) 1 публикация, 1.56%
JMIR Publications	JMIR Publications, 1, 1.56% JMIR Publications 1 публикация, 1.56%
AME Publishing Company	AME Publishing Company, 1, 1.56% AME Publishing Company 1 публикация, 1.56%
	2 4 6 8 10 12 14

Мы не учитываем публикации, у которых нет DOI.
Статистика публикаций обновляется еженедельно.

Вы ученый?

Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.

Войти с ORCID

Метрики

Цитировать

ГОСТ |

Цитировать

ГОСТ Скопировать

Busca A. et al. COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP // Blood advances. 2022. Vol. 6. No. 7. pp. 2427-2433.

ГОСТ со всеми авторами (до 50) Скопировать

Busca A., Salmanton-García J., Corradini P., Marchesi F., Cabirta A., DI BLASI R., Dulery R., Lamure S., Farina F., Weinbergerova B., Batinić J., Nordlander A., Lopez-Garcia A., Drgona L., Espigado I., Falces-Romero I., García-Sanz R., Garcia-Vidal C., Guidetti A., Khanna N., Kulasekararaj A., Maertens J. A., Hoenigl M., Klimko N., Koehler P., Pagliuca A., Passamonti F., Cornely O. A., Pagano L. COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP // Blood advances. 2022. Vol. 6. No. 7. pp. 2427-2433.

RIS |

Цитировать

RIS Скопировать

TY - JOUR

DO - 10.1182/bloodadvances.2021005616

UR - https://doi.org/10.1182/bloodadvances.2021005616

TI - COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP

T2 - Blood advances

AU - Busca, A.

AU - Salmanton-García, J.

AU - Corradini, P

AU - Marchesi, F.

AU - Cabirta, Alba

AU - DI BLASI, R.

AU - Dulery, R.

AU - Lamure, S

AU - Farina, Francesca

AU - Weinbergerova, Barbora

AU - Batinić, Josip

AU - Nordlander, Anna

AU - Lopez-Garcia, Alberto

AU - Drgona, Lubos

AU - Espigado, Ildefonso

AU - Falces-Romero, Iker

AU - García-Sanz, Ramón

AU - Garcia-Vidal, Carolina

AU - Guidetti, Anna

AU - Khanna, N

AU - Kulasekararaj, A.

AU - Maertens, Johan A.

AU - Hoenigl, M.

AU - Klimko, N.

AU - Koehler, Philipp

AU - Pagliuca, Antonio

AU - Passamonti, Francesco

AU - Cornely, Oliver A.

AU - Pagano, Livio

PY - 2022

DA - 2022/04/11

PB - American Society of Hematology

SP - 2427-2433

IS - 7

VL - 6

PMID - 34749396

SN - 2473-9537

SN - 2473-9529

ER -

BibTex |

Цитировать

BibTex (до 50 авторов) Скопировать

@article{2022_Busca,

author = {A. Busca and J. Salmanton-García and P Corradini and F. Marchesi and Alba Cabirta and R. DI BLASI and R. Dulery and S Lamure and Francesca Farina and Barbora Weinbergerova and Josip Batinić and Anna Nordlander and Alberto Lopez-Garcia and Lubos Drgona and Ildefonso Espigado and Iker Falces-Romero and Ramón García-Sanz and Carolina Garcia-Vidal and Anna Guidetti and N Khanna and A. Kulasekararaj and Johan A. Maertens and M. Hoenigl and N. Klimko and Philipp Koehler and Antonio Pagliuca and Francesco Passamonti and Oliver A. Cornely and Livio Pagano},

title = {COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP},

journal = {Blood advances},

year = {2022},

volume = {6},

publisher = {American Society of Hematology},

month = {apr},

url = {https://doi.org/10.1182/bloodadvances.2021005616},

number = {7},

pages = {2427--2433},

doi = {10.1182/bloodadvances.2021005616}

}

MLA

Цитировать

MLA Скопировать

Busca, A., et al. “COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP.” Blood advances, vol. 6, no. 7, Apr. 2022, pp. 2427-2433. https://doi.org/10.1182/bloodadvances.2021005616.

Издатель

American Society of Hematology

Журнал

Blood advances

scimago Q1

wos Q1

БС1

SJR

2.901

CiteScore

11.7

Impact factor

7.1

ISSN

24739537 (Electronic)

24739529 (Print)